Literature DB >> 9630370

Pathogenesis of Clostridium difficile infection.

S P Borriello1.   

Abstract

Clostridium difficile produces two major toxins referred to as toxins A and B. These are thought to be primarily responsible for the virulence of the bacterium and the major contributors to the pathogenesis of antibiotic-associated gastrointestinal disease. The molecular organization and control of expression of toxins A and B is now starting to be understood, and the cellular mechanism of action of both toxins, glucosylation of Rho family proteins, has been discovered. Other factors, such as production of proteolytic and hydrolytic enzymes, expression of fimbriae and flagella, chemotaxis and adhesion to gut receptors, and production of capsule, may all play a part in pathogenesis by facilitating colonization or by directly contributing to tissue damage, or both. Differential expression between strains of various combinations of these colonization and virulence factors may explain the apparent variability in virulence of C. difficile strains.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630370     DOI: 10.1093/jac/41.suppl_3.13

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  46 in total

Review 1.  Review of medical and surgical management of Clostridium difficile infection.

Authors:  B Faris; A Blackmore; N Haboubi
Journal:  Tech Coloproctol       Date:  2010-05-08       Impact factor: 3.781

2.  Development and evaluation of an ovine antibody-based platform for treatment of Clostridium difficile infection.

Authors:  April Roberts; Joanna McGlashan; Ibrahim Al-Abdulla; Roger Ling; Harriet Denton; Steve Green; Ruth Coxon; John Landon; Clifford Shone
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

3.  Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts.

Authors:  Trevor D Lawley; Simon Clare; Alan W Walker; David Goulding; Richard A Stabler; Nicholas Croucher; Piero Mastroeni; Paul Scott; Claire Raisen; Lynda Mottram; Neil F Fairweather; Brendan W Wren; Julian Parkhill; Gordon Dougan
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

4.  Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications.

Authors:  Ramsey M Dallal; Brian G Harbrecht; Arthur J Boujoukas; Carl A Sirio; Linda M Farkas; Kenneth K Lee; Richard L Simmons
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

5.  Mouse relapse model of Clostridium difficile infection.

Authors:  Xingmin Sun; Haiying Wang; Yongrong Zhang; Kevin Chen; Barbara Davis; Hanping Feng
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

6.  Toxic megacolon from hypervirulent Clostridium difficile infection (ribotype 027) following elective total knee replacement: an emerging challenge in modern health care.

Authors:  Buchi Rajendra Babu Arumilli; Prasanthi Koneru; Irfan Fayyaz
Journal:  BMJ Case Rep       Date:  2010-01-13

7.  Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France.

Authors:  Frédéric Barbut; Valérie Lalande; Béatrice Burghoffer; Huong Vu Thien; Emmanuel Grimprel; Jean-Claude Petit
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

8.  Colonic IgA producing cells and macrophages are reduced in recurrent and non-recurrent Clostridium difficile associated diarrhoea.

Authors:  S S Johal; C P Lambert; J Hammond; P D James; S P Borriello; Y R Mahida
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

9.  Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile.

Authors:  M F De La Cochetière; T Durand; V Lalande; J C Petit; G Potel; L Beaugerie
Journal:  Microb Ecol       Date:  2008-01-22       Impact factor: 4.552

10.  Morphological and genetic diversity of temperate phages in Clostridium difficile.

Authors:  Louis-Charles Fortier; Sylvain Moineau
Journal:  Appl Environ Microbiol       Date:  2007-09-21       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.